Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89035207

FUT4, anti-Human, Clone: FUT4/1478R, Abnova™

Catalog No. 89035207 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-035-207 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-035-207 Supplier Abnova Corporation Supplier No. RAB00328
Add to Cart
Add to Cart

Description

Monoclonal Antibody

Specifications

Antigen FUT4
Applications Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone FUT4/1478R
Conjugate Unconjugated
Dilution Flow Cytometry (2-4 ug/106 cells) Immunofluorescence (2-4 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (5-10 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In 10 mM PBS.
Gene fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
Gene Alias CD15/ELFT/FCT3A/FUC-TIV/FUTIV
Gene Symbols FUT4
Immunogen Purified human neutrophils.
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 2526
Target Species Human
Content And Storage Store at -20 to -80°C. Aliquot to avoid repeated freezing and thawing.
Product Type Antibody
Form Liquid
Isotype IgG κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.